Shandong Weigao Group Medical Polymer Company Limited
SHWGF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.62 | -0.36 | 0.19 | -0.30 |
| FCF Yield | 3.53% | 5.12% | 3.18% | 3.29% |
| EV / EBITDA | 13.13 | 12.84 | 16.96 | 20.64 |
| Quality | ||||
| ROIC | 3.22% | 2.45% | 3.64% | 2.91% |
| Gross Margin | 49.72% | 48.97% | 50.88% | 48.44% |
| Cash Conversion Ratio | 0.87 | 1.84 | 0.92 | 2.09 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.82% | 6.14% | 9.41% | 12.02% |
| Free Cash Flow Growth | -24.60% | 14.31% | -1.07% | -7.46% |
| Safety | ||||
| Net Debt / EBITDA | -2.10 | -2.40 | -2.00 | -2.04 |
| Interest Coverage | 10.07 | 0.00 | 9.81 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.46 | 1.30 | 1.41 | 1.31 |
| Cash Conversion Cycle | 52.77 | 55.74 | 40.88 | 53.89 |